Researchers Have Developed New Immune Tracking Model
The computational tool predicts protein expression to identify immune aging and lupus-related cell shifts.
Updated on Sept. 22, 2026 in Biotech
Researchers have developed a new computational model called scEN to predict protein expression from gene expression. The tool provides insights into immune cell subsets and identifies how lupus accelerates immune aging.
Why it matters
The model enables protein-based characterization of immunophenotypic diversity within existing scRNA-seq data. This helps scientists better understand immune system changes and disease-driven shifts at a single-cell resolution.
The scEN model utilizes a regularized Elastic Net regression framework to translate gene expression into protein data. It was trained using paired transcriptomic and surface-protein measurements derived from CITE-seq bone marrow datasets.
The players
scEN
This is a computational model designed to predict protein expression from gene expression data using regularized Elastic Net regression.
The details
By processing single-cell RNA sequencing data, scEN identifies immune-cell subsets associated with natural aging. It specifically reveals how lupus conditions induce measurable shifts among these immune-cell populations.
Timeline
September 22, 2026: The research findings were formally published.
The Tech Race
This innovation follows a trend of increasing reliance on CITE-seq datasets to bridge the gap between transcriptomic data and functional protein analysis. It marks a shift toward leveraging advanced regression models to extract deeper biological insights from existing single-cell sequencing architectures.
Researchers and software developers can now use this model to gain higher-resolution insights from single-cell data without requiring new complex protein assays. This workflow improvement accelerates the speed at which scientists can identify disease biomarkers and aging markers.
The takeaway
The development of scEN demonstrates how computational tools can expand the utility of biological datasets without needing additional laboratory experiments. Future studies may use this approach to map how other chronic diseases influence the immune system over time.
Further reading
Learn more about the latest innovations in Biotech.
